Related references
Note: Only part of the references are listed.Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome
Martina Parrini et al.
MOLECULAR THERAPY (2021)
Measuring Anxiety-Like Behaviors in Rodent Models of Traumatic Brain Injury
Laura B. Tucker et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)
Forebrain Shh overexpression improves cognitive function and locomotor hyperactivity in an aneuploid mouse model of Down syndrome and its euploid littermates
Feng J. Gao et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Burden of family caregivers of Down syndrome children: a cross-sectional study
Nadia Alam El-Deen et al.
FAMILY PRACTICE (2021)
Skeletal dynamics of Down syndrome: A developing perspective
Jonathan M. LaCombe et al.
BONE (2020)
Interaction of sexual dimorphism and gene dosage imbalance in skeletal deficits associated with Down syndrome
Jared R. Thomas et al.
BONE (2020)
Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome
Javier Zorrilla de San Martin et al.
ELIFE (2020)
Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice
Charles R. Goodlett et al.
SCIENTIFIC REPORTS (2020)
Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
R. Velazquez et al.
MOLECULAR NEUROBIOLOGY (2019)
Characteristics Associated with Autism Spectrum Disorder Risk in Individuals with Down Syndrome
Marie Moore Channell et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2019)
Decreasing the Expression of GABAA α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome
Veronica Vidal et al.
MOLECULAR NEUROBIOLOGY (2018)
Developmental trend of children with Down's syndrome - How do sex and neonatal conditions influence their developmental patterns?
Sayaka Aoki et al.
BRAIN & DEVELOPMENT (2018)
Memory profiles in Down syndrome across development: a review of memory abilities through the lifespan
Mary Godfrey et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2018)
The GABAAα5-selective Modulator, RO4938581, Rescues Protein Anomalies in the Ts65Dn Mouse Model of Down Syndrome
A. Block et al.
NEUROSCIENCE (2018)
Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature
Thu Lan Nguyen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes
Megan Stringer et al.
PHYSIOLOGY & BEHAVIOR (2017)
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits
Megan Stringer et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Burden of caregivers of children and adolescents with Down Syndrome
Alina Lucia Oliveira Barros et al.
CIENCIA & SAUDE COLETIVA (2017)
Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome
J. Luis Olmos-Serrano et al.
EXPERIMENTAL NEUROLOGY (2016)
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
Benjamin J. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Designer Receptors Enhance Memory in a Mouse Model of Down Syndrome
Ashley M. Fortress et al.
JOURNAL OF NEUROSCIENCE (2015)
Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome
Aaron Block et al.
BIOLOGY OF SEX DIFFERENCES (2015)
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Rafael De la Torre et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage
Benoit Souchet et al.
NEUROBIOLOGY OF DISEASE (2014)
Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
Susana Garcia-Cerro et al.
PLOS ONE (2014)
New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome
Joongkyu Park et al.
Experimental Neurobiology (2014)
Modeling Transformations of Neurodevelopmental Sequences across Mammalian Species
Alan D. Workman et al.
JOURNAL OF NEUROSCIENCE (2013)
Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle
Jia-Yun Chen et al.
MOLECULAR CELL (2013)
Total Protein Analysis as a Reliable Loading Control for Quantitative Fluorescent Western Blotting
Samantha L. Eaton et al.
PLOS ONE (2013)
Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model
Ishita Das et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Novel PCR Assay for Determining the Genetic Sex of Mice
L. McFarlane et al.
SEXUAL DEVELOPMENT (2013)
Developmentally altered inhibition in Ts65Dn, a mouse model of Down syndrome
Ananya Mitra et al.
BRAIN RESEARCH (2012)
Increased efficiency of the GABAA and GABAB receptor-mediated neurotransmission in the Ts65Dn mouse model of Down syndrome
Alexander M. Kleschevnikov et al.
NEUROBIOLOGY OF DISEASE (2012)
Trisomy 21 and early brain development
Tarik F. Haydar et al.
TRENDS IN NEUROSCIENCES (2012)
Widespread Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with Down Syndrome
Sandra Guidi et al.
BRAIN PATHOLOGY (2011)
Structural basis of CX-4945 binding to human protein kinase CK2
Andrew D. Ferguson et al.
FEBS LETTERS (2011)
Direct Health Care Costs of Children and Adolescents with Down Syndrome
Elizabeth A. Geelhoed et al.
JOURNAL OF PEDIATRICS (2011)
Coomassie Staining as Loading Control in Western Blot Analysis
Charlotte Welinder et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn
Laura G. Reinholdt et al.
MAMMALIAN GENOME (2011)
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of pradrenergic receptor by xamoterol as a potential cognitive enhancer
Mehrdad Faizi et al.
NEUROBIOLOGY OF DISEASE (2011)
Updated National Birth Prevalence Estimates for Selected Birth Defects in the United States, 2004-2006
Samantha E. Parker et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2010)
Dyrk1A Overexpression Inhibits Proliferation and Induces Premature Neuronal Differentiation of Neural Progenitor Cells
Odessa Yabut et al.
JOURNAL OF NEUROSCIENCE (2010)
Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome
Lina Chakrabarti et al.
NATURE NEUROSCIENCE (2010)
The Down Syndrome Critical Region Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome
Nadia P. Belichenko et al.
JOURNAL OF NEUROSCIENCE (2009)
Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system
Jennifer L. Hanslick et al.
NEUROBIOLOGY OF DISEASE (2009)
The use of total protein stains as loading controls: An alternative to high-abundance single-protein controls in semi-quantitative immunoblotting
Georgina M. Aldridge et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Down syndrome gene dosage imbalance on cerebellum development
Randal X. Moldrich et al.
PROGRESS IN NEUROBIOLOGY (2007)
Chronobiometry of behavioral activity in the Ts65Dn model of Down syndrome
Lee S. Stewart et al.
BEHAVIOR GENETICS (2007)
Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome
C Martínez-Cué et al.
GENES BRAIN AND BEHAVIOR (2006)
DYRKIA BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Kyoung-Jin Ahn et al.
NEUROBIOLOGY OF DISEASE (2006)
Perinatal loss of Ts65Dn Down syndrome mice
RJ Roper et al.
GENETICS (2006)
Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4
JH Sitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model
NG Saran et al.
HUMAN MOLECULAR GENETICS (2003)
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review
L Prut et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome
C Martínez-Cué et al.
BEHAVIOURAL BRAIN RESEARCH (2002)
Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes
FX Castellanos et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome
X Altafaj et al.
HUMAN MOLECULAR GENETICS (2001)
Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse
LL Baxter et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
